General

In a rapidly evolving landscape of healthcare technology, the practical application of AI outweighs the technology's mere development in significance. The Korean Institute of...

Sanofi surges forward in the field of immunotherapy as the US FDA grants priority review to their innovative drug, Tzield (teplizumab-mzwv). Tzield targets young...

In a crucial development for medical technology enthusiasts and investors, TransMedics Group, Inc., known for its innovative organ transplant solutions, is gearing up to...

Catalonia's BioRegion experienced an extraordinary year, marked by substantial investment influxes, scientific breakthroughs, and transformative entrepreneurial initiatives that cemented its role as a European...

UCB hosted its third Epilepsy Digital Roundtable on December 3, 2025, marking a significant commitment towards enhancing patient outcomes through digital health initiatives. The...

The European Medicines Agency (EMA) convened a pivotal meeting with stakeholders to address the future of pharmaceutical policies. Held both online and in-person, this...

Amplifon, renowned for its hearing solutions worldwide, introduces a heartwarming Christmas campaign named 'The Wish,' placing the spotlight on the profound impact of genuine...

The Union Product Database (UPD) serves as an essential tool in the management of veterinary medicinal products across the European Union. This pivotal resource...

Navigating the complex landscape of rare diseases, the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) plays a crucial role in evaluating and...

The Committee for Veterinary Medicinal Products (CVMP) has given its nod for the marketing authorization of Firocoxib CP-Pharma, a chewable NSAID tablet for canine...

Pharmaceutical giant Orion is gearing up for a significant leap in its 2025 financial outlook, bolstered by an anticipated payment of €180 million connected...

In an effort to streamline regulatory processes and address stakeholder queries, the European Medicines Agency (EMA) offers monthly Q&A sessions focused on Substance, Organisation,...

The European Medicines Agency (EMA) convened its Committee for Advanced Therapies (CAT) on December 3-5, 2025, in Amsterdam, focusing on a comprehensive agenda aimed...

In a landmark move, HIQA has rolled out fresh national guidance aimed at elevating communication standards in health and social care. This comprehensive blueprint...

The 129th meeting of the European Medicines Agency's (EMA) Management Board unfolded virtually in Amsterdam on October 2, 2025, presenting an important platform for...